Response to the Letter by Kataoka, et al. Regarding the Article, "Investigation of Stroke Risk Factors and Prognostic Indicators in NVAF Patients with Low CHA2DS2-VASc Scores"-Reference-Cited by-同舟云学术

Response to the Letter by Kataoka, et al. Regarding the Article, "Investigation of Stroke Risk Factors and Prognostic Indicators in NVAF Patients with Low CHA2DS2-VASc Scores"

Published:2024-05-31 Issue:3 Volume:65 Page:592-592
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Gao Tang-Gang¹,Liu Sui-Feng¹

Affiliation:

1. Department of Cardiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University

Publisher

International Heart Journal (Japanese Heart Journal)

Link

https://www.jstage.jst.go.jp/article/ihj/65/3/65_24-174/_pdf

Reference6 articles.

1. 1. Gao TG, Gao F, Huang WB, et al. Investigation of Stroke Risk Factors and Prognostic Indicators in NVAF Patients with Low CHA₂DS₂-VASc Scores. Int Heart J 2023; 64: 1040-8.

2. 2. Grönberg T, Hartikainen JE, Nuotio I, et al. Anticoagulation, CHA2DS2VASc score, and thromboembolic risk of cardioversion of acute atrial fibrillation (from the FinCV study). Am J Cardiol 2016; 117: 1294-8.

3. 3. Garg A, Khunger M, Seicean S, et al. Incidence of thromboembolic complications within 30 days of electrical cardioversion performed within 48 hours of atrial fibrillation onset. JACC Clin Electrophysiol 2016; 2: 487-94.

4. 4. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411-20.

5. 5. Chinese Society of Cardiology, Chinese Medical Association, Heart Rhythm Committee of Chinese Society of Biomedical Engineering. Chinese guidelines on diagnosis and management of atrial fibrillation. Chin J Cardiol 2023; 51: 572-618.